ONCOassist Deployed in The Clatterbridge Cancer Centre as Enterprise System

Portable Medical Technology LtdPortable Medical Technology and The Clatterbridge Cancer Centre NHS Foundation Trust have announced an enterprise agreement which will see ONCOassist, Portable Medical Technology's revolutionary CE approved software system being deployed as the main oncology decision support system used within Clatterbridge.

ONCOassist was launched in January of last year following extensive development involving oncologists, system developers and compliance personnel in Europe and the United States. Since launch ONCOassist has garnered growing acceptance amongst oncology professionals throughout the UK and Ireland. In August of this year, the platform was offered as an enterprise system. This enables individual trusts and institutions to integrate their guidelines and protocols and make them available throughout the trust in an easy to access and intuitive format across multiple mobile operating systems including iOS, Android and Windows.

The Clatterbridge Cancer Centre, based in Wirral, Merseyside, have been working closely with the ONCOassist team over the past twelve months and an enterprise agreement was the logical next step. "After many discussions with Clatterbridge we realised that, as access to the most up to date version of their protocol library was so important, developing a guidelines and protocols engine that allows for the easy integration and updating of trust specific content that can interact with the many CE approved tools already present on the platform would be of huge benefit," said Eoin O’Carroll of ONCOassist.

Thomas Poulter, Head of IM&T at The Clatterbridge Cancer Centre, said: "Having ONCOassist available in clinics and on the wards will save our clinicians time. The oncology nurses and clinicians will have access to all of the key oncology decision support information and tools they need. For example, our nurses often need to reference protocols or treatment algorithms when delivering chemotherapy treatment. ONCOassist makes it easy to do this."

Jo Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge Cancer Centre, said: "A cancer nurse's role is continually evolving to meet the needs of our patients. Important decisions relating to the management of treatment side-effects and the patient experience of their treatment are fast becoming central to the cancer nurse's role, especially in the outpatient setting. It is essential that vital information to aid decision-making in practice is quick and easy to access. I have found that the ONCOassist app provides easy access to formulas and decision-support information in my day-to-day job."

Kevin Bambury of ONCOassist said: "We are delighted to have The Clatterbridge Cancer Centre as the first NHS trust using our enterprise system. We look forward to working with them over the coming years as we continue to add features and functionality to the system."

About Portable Medical Technology
Portable Medical Technology Ltd develops quality, accredited and trusted apps for medical specialists to reduce medical errors, improve efficiencies and progress patient communication. We combine the essential tools specialists need into a single, easy-to-use smartphone and table application that are FDA and CE approved and provide the latest updated tools to support critical medical decision-making.

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...